Literature DB >> 8079668

Further definition of the protein kinase C activation domain of the parathyroid hormone.

H Jouishomme1, J F Whitfield, L Gagnon, S Maclean, R Isaacs, B Chakravarthy, J Durkin, W Neugebauer, G Willick, R H Rixon.   

Abstract

The protein kinase C (PKC) activation domain of the parathyroid hormone (PTH) was believed to be the 28-34 region of the molecule. We have now shown that PTH-(29-32) is the smallest PTH fragment that can stimulate significantly membrane-associated PKC activity in ROS 17/2 rat osteosarcoma cells. As was previously shown for full-length PTH-(1-84) and the fully bioactive PTH-(1-34) fragment, there were two peaks in the PKC response to PTH-(29-32): one peak was obtained with low picomolar concentrations and the other with much higher nanomolar concentrations of the fragment. The PKC-activating ability was unaffected by the loss of Asn33 and Phe34, but it was abolished by removing His32. Thus, the PTH-(28-31) and PTH-(29-31) fragments did not stimulate membrane-associated PKC activity. The much larger PTH-(1-31) fragment also did not stimulate membrane-associated PKC activity, although it stimulated adenylyl cyclase as strongly as PTH-(1-34). This functional sensitivity to the loss of the polar His32 was not caused by a specific need for His or another polar amino acid in this position because replacing it with the apolar Leu did not abolish adenylyl cyclase or PKC activation. It is concluded that the minimum, fully functional PKC activation domain of the PTH molecule is Gln29-Asp30-Val31-His32.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8079668     DOI: 10.1002/jbmr.5650090620

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  19 in total

Review 1.  Interaction of PTH and PTHrP with their receptors.

Authors:  T J Gardella; H Jüppner
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

2.  Effects of age on parathyroid hormone signaling in human marrow stromal cells.

Authors:  Shuanhu Zhou; Ericka M Bueno; Sung Won Kim; Ilaria Amato; Longxiang Shen; Jochen Hahne; Ilan Bleiberg; Paul Morley; Julie Glowacki
Journal:  Aging Cell       Date:  2011-05-25       Impact factor: 9.304

3.  Individual and combined effects of calciotropic hormones and growth factors on mineral metabolism in embryonic chick tibiae.

Authors:  C Duvos; A Scutt; H Mayer
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-06       Impact factor: 2.416

4.  Acute down-regulation of sodium-dependent phosphate transporter NPT2a involves predominantly the cAMP/PKA pathway as revealed by signaling-selective parathyroid hormone analogs.

Authors:  So Nagai; Makoto Okazaki; Hiroko Segawa; Clemens Bergwitz; Thomas Dean; John T Potts; Matthew J Mahon; Thomas J Gardella; Harald Jüppner
Journal:  J Biol Chem       Date:  2010-11-03       Impact factor: 5.157

5.  Contributions of parathyroid hormone (PTH)/PTH-related peptide receptor signaling pathways to the anabolic effect of PTH on bone.

Authors:  D Yang; R Singh; P Divieti; J Guo; M L Bouxsein; F R Bringhurst
Journal:  Bone       Date:  2007-02-16       Impact factor: 4.398

6.  Intermittent PTH(1-34) signals through protein kinase A to regulate osteoprotegerin production in human periodontal ligament cells in vitro.

Authors:  Dominik Kraus; Andreas Jäger; Nuersailike Abuduwali; James Deschner; Stefan Lossdörfer
Journal:  Clin Oral Investig       Date:  2011-03-29       Impact factor: 3.573

7.  Restoration of severely depleted femoral trabecular bone in ovariectomized rats by parathyroid hormone-(1-34).

Authors:  J F Whitfield; P Morley; V Ross; R J Isaacs; R H Rixon
Journal:  Calcif Tissue Int       Date:  1995-03       Impact factor: 4.333

8.  Mesenchymal progenitors residing close to the bone surface are functionally distinct from those in the central bone marrow.

Authors:  Valerie A Siclari; Ji Zhu; Kentaro Akiyama; Fei Liu; Xianrong Zhang; Abhishek Chandra; Hyun-Duck Nah; Songtao Shi; Ling Qin
Journal:  Bone       Date:  2012-12-27       Impact factor: 4.398

Review 9.  Translating in vitro ligand bias into in vivo efficacy.

Authors:  Louis M Luttrell; Stuart Maudsley; Diane Gesty-Palmer
Journal:  Cell Signal       Date:  2017-05-07       Impact factor: 4.315

10.  Agonist-regulated cleavage of the extracellular domain of parathyroid hormone receptor type 1.

Authors:  Christoph Klenk; Stefan Schulz; Davide Calebiro; Martin J Lohse
Journal:  J Biol Chem       Date:  2010-01-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.